Ismail Lourido Ali (MAPS): The Work No Executive Order Can Do
"We can pass 10 executive orders. We can put $500 million for drug development. And if we don't have people who are willing to hold that space... we're not going to get anywhere." - Ismail Lourido Ali...
21 Huhti 1h 10min
Robin Arnott & Sandeep Prakash: Training for Psychedelic Surrender
Can we practice the art of surrender before the first dose?Today on the show Robin Arnott and Dr. Sandeep Prakash explain how SoundSelf evolved from a VR curiosity into a clinically oriented tool that...
25 Huhti 202555min
Joshua White: Who You Gonna Call? Fireside
Imagine you’re in the middle of a psychedelic journey—things are getting intense, and you just need someone to talk to. That’s whereFireside Project comes in. As the world’s first psychedelic peer sup...
13 Helmi 20251h 14min
Tom Feegel: Ibogaine for Cognitive Enhancement
A month ago, I had the privilege of visiting Beond in Cancun, Mexico to experience an ibogaine treatment for cognitive enhancement. Today, I’m joined by Beond CEO Tom Feegel to discuss how this remark...
27 Tammi 20251h 6min
Juan Pablo Capello: A Wakeup Call for Ketamine Telehealth Companies
Today, I’m joined by Juan Pablo Capello, co-founder and former CEO of New Life Health, a telehealth ketamine therapy service launched in 2021. Juan Pablo has raised concerns about low standards of car...
20 Marras 20241h 4min
Natalie Lyla Ginsberg (MAPS): The FDA, MDMA, and the Future of Psychedelic Therapy
Today, we’re exploring a critical issue facing the field of psychedelic medicine: the recent FDA rejection of MAPS’ clinical trials to reschedule MDMA for therapeutic use. This setback affects many of...
28 Loka 20241h 3min
Tricia Eastman & Joseph Barsuglia: Ibogaine is Miracle Grow for the Brain
Today we’re doing something a little different. I’m re-releasing an episode from my personal podcast, Life is a Festival, because it remains one of my favorite interviews ever. This conversation, orig...
18 Loka 20241h 9min
Jennifer Tippett: Understanding Private Practice vs Clinical Trials
After the shocking decision of an advisory committee recommendation that the FDA reject MDMA as a treatment for post-traumatic stress disorder, I wanted to speak to someone who understands the differe...
8 Elo 202446min
